UNSPSC 51473306: Resorcin or resorcinol

This classification denotes a topical anti-infective agent with the molecular formula C6H6O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YUL4LO94HK, chemically known as 1,3-dihydroxybenzene but generally known as resorcin, which bears US NIH Compound Identifier 5054. European Medicines Agency schedules Resorcinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15120MIG. World Health Organization schedules resorcin in its Anatomical Therapeutic Chemical (ATC) Classification.

Resorcin or resorcinol bears US NLM identifiers UMLS ID C0073085 and NCI Concept Code C77056. SMILES: C1=CC(=CC(=C1)O)O.

UNSPSC 51473306 Resorcin or resorcinol, a Commodity code, covers chemical compounds used in pharmaceutical manufacturing, industrial processes, and consumer products, though recent state and local solicitations tagged with this code show minimal direct relevance to the resorcin/resorcinol product itself. State and local buyers posting under this code are primarily county procurement offices and multi-state cooperative purchasing alliances seeking consumable supplies and pharmaceutical products for operational and healthcare use. The solicitation mix reflects broader janitorial, operational supply, and pharmaceutical procurement activity rather than specific procurement of resorcin or resorcinol as a standalone chemical input.

Recent activity includes Hillsborough County Board of County Commissioners (Florida) issuing an ITB for consumable janitorial and operational supplies due July 24, 2026, with an estimated contract value of $765,679.84 for one year of supply to the Hillsborough County Fire Rescue Department, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issuing an RFP for generic multi-source pharmaceuticals and over-the-counter products with a March 26, 2026 response date and July 1, 2026 contract effective date across participating state and local government facilities including Oregon. Geographic concentration is limited; activity appears concentrated in Florida and Minnesota/multi-state cooperative structures. The code shows little direct procurement of resorcin or resorcinol as a discrete chemical commodity at the state and local level based on recent posted opportunities.